Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

MEA Anti Fungal Agents Market

ID: MRFR/Pharma/1942-HCR
84 Pages
Satyendra Maurya
Last Updated: April 06, 2026

Anti-Fungal Agents Market Research Report Information, by Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis and Others), Drug Class (Azoles, Pyrimidines, Echinocandins, Polyenes, Allylamines and Others) and Route of Administration (Oral, Local and Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

MEA Anti Fungal Agents Market Infographic
Purchase Options
  1. 1 Introduction
    1. 1.1 Definition
    2. 1.2 Scope of
    3. Study
    4. 1.3 Research Objective
    5. 1.4 Assumptions & Limitations
    6. Market Structure:
  2. 2 Research Methodology
    1. 2.1 Research Process
    2. Primary Research
    3. 2.3 Secondary Research
  3. 3 Market Dynamics
    1. 3.1 Drivers
    2. 3.2 Restraints
    3. 3.3 Opportunities
    4. 3.4 Challenges
    5. 3.5 Macroeconomic
    6. Indicators
  4. 4 Market Factor Analysis
    1. 4.1 Porter’s five forces model
      1. 4.1.1 Bargaining Power of suppliers
      2. 4.1.2 Bargaining Power of Customer
      3. 4.1.3 Intensity of Competitor’s
      4. 4.1.4 Threat of New Entrants
  5. MEA Anti Fungal Agents Market, by Therapeutic Indication
    1. 5.1 Introduction
      1. 5.1.1 Aspergillosis
      2. 5.1.2 Dermatophytosis
      3. 5.1.4 Others
    2. Candidiasis
  6. 6 MEA Anti Fungal Agents Market,
    1. by Drug Class
    2. 6.1 Introduction
      1. 6.1.1 Azoles
      2. 6.1.2 Pyrimidines
      3. 6.1.3 Echinocandins
      4. 6.1.4 Polyenes
      5. 6.1.5 Allylamines
      6. 6.1.6 Others
  7. 7 MEA Anti Fungal Agents Market, by Route of Administration
    1. 7.1 Introduction
      1. 7.1.1 Oral
      2. 7.1.3 Local
      3. 7.1.4 Others
  8. 8 Middle
  9. MEA Anti Fungal Agents Market, by Country
    1. 8.1 Introduction
    2. UAE
    3. 8.3 Egypt
    4. 8.4 Saudi Arabia
    5. 8.5 Kuwait
    6. 8.6 Qatar
    7. Oman
  10. 9 Company Landscape
    1. 9.1 Introduction
      1. 9.1.1 Mergers Acquisitions
      2. 9.1.2 Collaborations
      3. 9.1.3 Release/New Product Launches
      4. 9.1.4 Other
    2. (Expansion, Updates, Partnership)
  11. 10 Company Profile
    1. 10.1 Novartis AG
      1. 10.1.1 Company Overview
      2. 10.1.2 Product/Business Segment Overview
      3. 10.1.4 Key Developments
      4. 10.1.5 SWOT Analysis
    2. Financials
    3. 10.2 Pfizer,
      1. 10.2.1 Overview
      2. 10.2.2 Product/Business Segment Overview
      3. 10.2.4 Key Developments
      4. 10.2.5 SWOT Analysis
    4. Inc.
    5. Financials
    6. 10.3 Sanofi-Aventis
      1. 10.3.1 Overview
      2. 10.3.2 Product/Business Segment Overview
      3. 10.3.4 Key Developments
      4. 10.3.5 SWOT Analysis
    7. Financials
    8. 10.4 Merck
      1. 10.4.1 Overview
      2. 10.4.2 Product/Business Segment Overview
      3. 10.4.3 Financials
      4. 10.4.4 Key Developments
      5. 10.4.5 SWOT Analysis
      6. 10.5.1 Overview
      7. 10.5.2 Product/Business Segment
      8. 10.5.3 Financials
      9. 10.5.4 Key Developments
      10. 10.5.5 SWOT Analysis
    9. & Co.
    10. Enzon Pharmaceuticals
    11. Overview
    12. 10.6 Bayer AG
      1. 10.6.1 Overview
      2. 10.6.2 Product/Business Segment Overview
      3. 10.6.3 Financials
      4. 10.6.4 Key Developments
      5. 10.6.5 SWOT Analysis
      6. 10.7.1 Overview
      7. 10.7.2 Product/Business Segment Overview
      8. 10.7.3 Financials
      9. 10.7.4 Key Developments
      10. 10.7.5 SWOT Analysis
      11. 10.7.1 Overview
      12. 10.7.2 Product/Business Segment Overview
      13. 10.7.3 Financials
      14. 10.7.4 Key Developments
      15. 10.7.5 SWOT Analysis
      16. 10.7.1 Overview
      17. 10.7.2 Product/Business Segment Overview
      18. 10.7.4 Key Developments
      19. 10.7.5 SWOT Analysis
    13. Astellas Pharma
    14. GlaxoSmithKline plc
    15. Abbott
    16. Financials
    17. 10.7 Sigma-Aldrich
      1. 10.7.1 Overview
      2. 10.7.2 Product/Business Segment Overview
      3. 10.7.3 Financials
      4. 10.7.4 Key Developments
      5. 10.7.5 SWOT Analysis
    18. 10.8 Others
  12. 11 Appendix
    1. List of Tables
  13. TABLE 1 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS MARKET,
    1. MEA Anti Fungal Agents Market,
    2. BY THERAPEUTIC INDICATION,2023-2030 (USD MILLION)
  14. TABLE 3 MIDDLE EAST AND AFRICA
  15. MEA Anti Fungal Agents Market, BY DRUG CLASS, 2023-2030 (USD MILLION)
  16. TABLE 4 MIDDLE
  17. MEA Anti Fungal Agents Market, BY ROUTE OF ADMINISTRATION, 2023-2030
    1. (USD MILLION)
    2. MEA Anti Fungal Agents Market, BY
    3. REGION, 2023-2030 (USD MILLION)
    4. List of Figures
  18. FIGURE 1 RESEARCH PROCESS
  19. FIGURE 2 PORTERS FIVE FORCES MODEL
  20. FIGURE 3 MIDDLE EAST AND AFRICA ANTI-FUNGAL
  21. MEA Anti Fungal Agents Market, BY THERAPEUTIC INDICATION
  22. FIGURE 4 MIDDLE EAST AND AFRICA ANTI-FUNGAL
  23. MEA Anti Fungal Agents Market, BY DRUG CLASS
  24. FIGURE 5 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS
  25. MEA Anti Fungal Agents Market, BY ROUTE OF ADMINISTRATION
  26. FIGURE 6 MIDDLE EAST AND AFRICA ANTI-FUNGAL
  27. MEA Anti Fungal Agents Market, BY REGION
  28. FIGURE 7 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS
    1. MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

Anti-Fungal Agents Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions